Literature DB >> 16882038

Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors.

Lynda M Pierini1.   

Abstract

The bacterium Francisella tularensis is highly infective, and this is one of the chief attributes that has led to its development as a bioweapon. Establishment of infection requires efficient uptake of F. tularensis by host macrophages, which provide a safe in vivo environment for F. tularensis replication. Little is known, however, about the cellular entry mechanisms employed by this organism. This report shows that efficient uptake of F. tularensis live vaccine strain (LVS) by macrophages is dependent on a heat-sensitive serum component and is mediated in part by types I and II class A scavenger receptors (SRA), demonstrating for the first time that SRA can act as a receptor for opsonized pathogens. Specifically, uptake of serum-opsonized LVS was partially blocked by general scavenger receptor inhibitors [fucoidan and poly(I)] and was largely inhibited by a specific function-blocking antibody against SRA. A role for SRA in LVS binding was confirmed by showing that ectopic expression of SRA in human embryonic kidney cells conferred the capacity for robust serum-dependent LVS binding. Finally, SRA-/- macrophages ingested significantly fewer LVS than did macrophages from wild-type mice. These findings support a novel role for SRA in innate immunity and suggest a potential therapeutic approach for modulating F. tularensis infection, namely, blocking SRA as a means of hindering F. tularensis access to its intracellular niche.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882038     DOI: 10.1111/j.1462-5822.2006.00719.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  46 in total

1.  The class A macrophage scavenger receptor type I (SR-AI) recognizes complement iC3b and mediates NF-κB activation.

Authors:  Jason W K Goh; Yen Seah Tan; Alister W Dodds; Kenneth B M Reid; Jinhua Lu
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

2.  Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.

Authors:  Stephen R Lindemann; Kaitian Peng; Matthew E Long; Jason R Hunt; Michael A Apicella; Denise M Monack; Lee-Ann H Allen; Bradley D Jones
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

4.  Outsmarting the host: bacteria modulating the immune response.

Authors:  Matthew D Woolard; Jeffrey A Frelinger
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain SCHU S4.

Authors:  Susan R Brock; Michael J Parmely
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

6.  Francisella tularensis phagosomal escape does not require acidification of the phagosome.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

7.  The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies.

Authors:  Heather J Ray; Ping Chu; Terry H Wu; C Rick Lyons; Ashlesh K Murthy; M Neal Guentzel; Karl E Klose; Bernard P Arulanandam
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Nucleolin, a shuttle protein promoting infection of human monocytes by Francisella tularensis.

Authors:  Monique Barel; Karin Meibom; Alain Charbit
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

9.  The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

Review 10.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.